ON DEMAND: ART24, a novel Live Biotherapeutic Product in development for the prevention of CDI
Date & Time
Friday, June 5, 2020, 9:00 AM - 5:00 PM
Laurent Chesnel

• Discover the key in vitro characteristics of ART24 related to its direct activities against C. difficile and its toxins

• Learn how the in vitro properties translate in an animal model of CDI 

• Explore the in vitro and in vivo impact of ART24 exposure on the faecal microbiota

• Describe the clinical development plan for Phase 1 focussing on safety and tolerability

Session Type
Virtual Session Link